Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients조혈모세포이식 및 CAR T-세포 치료 수혜자의 SARS-CoV-2 예방접종에 대한 면역반응Article Published on 2022-06-162022-09-12 Journal: Journal of Hematology & Oncology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] addition affected Analysis Antigen booster dose CAR CAR-T cellular response chimeric antigen receptor Chimeric antigen receptor T-cell (CAR-T) therapy conducted COVID-19 vaccine Efficacy evaluate healthy individuals Hematopoietic stem cell Hematopoietic stem cell transplantation (HSCT) HSCT HSCT recipients humoral immune response immunosuppressive increased risk indicated Lymphocyte count outcome Patient receptor recipient recipients required Research response to vaccination SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination Seroconversion significantly significantly higher Stem cell transplantation T-cell therapy Undetermined vaccination Vaccination strategy [DOI] 10.1186/s13045-022-01300-9 PMC 바로가기 [Article Type] Article
COVID-19 waves: variant dynamics and controlCOVID-19 파동: 변종 역학 및 제어Article Published on 2022-06-042022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, [키워드] caused COVID-19 COVID-19 infection COVID-19 infections delta variant driven by Infection modulated Novel coronavirus quarantine shown suppress vaccination Vaccination strategy Vaccines variant Waves [DOI] 10.1038/s41598-022-13371-2 PMC 바로가기 [Article Type] Article
Booster Vaccination Strategies for “Living With COVID-19”"COVID-19와 함께 살기"를 위한 추가 백신 접종 전략Article Published on 2022-06-032022-09-11 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종, [키워드] age age-specific vaccination booster booster shot strategies booster vaccination comorbid-group priority vaccination Comorbidities Comorbidity confirmed case COVID-19 effective Effectiveness Efficacy eight evaluate Factors group immune Impact Intervention investigated mathematical mathematical model morbidity morbidity and mortality Non-pharmaceutical intervention NPI NPIs omicron Omicron variant promote SARS-CoV-2 Strategy total population vaccinate vaccination vaccination rate vaccination rates Vaccination strategy Vaccinations Vaccine vaccine efficacy variant with COVID-19 [DOI] 10.3389/fpubh.2022.896713 PMC 바로가기 [Article Type] Article
Reconstruction of a large-scale outbreak of SARS-CoV-2 infection in Iceland informs vaccination strategiesArticle Published on 2022-06-012023-07-08 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), [키워드] COVID-19 Outbreak reconstruction SARS-CoV-2 Transmission tree Vaccination strategy [DOI] 10.1016/j.cmi.2022.02.012 PMC 바로가기
The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster VaccineSinopharm 백신 2회 접종 후 SARS-CoV-2 스파이크 항체 유도에 대한 연령, 성별 및 동반 질환의 영향과 Pfizer/BioNtech Booster 백신의 효과Article Published on 2022-05-302022-09-12 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome Administered age antibody antibody quantification Bahrain BBIBP-CorV BNT162b2 booster booster dose cause China clinical conditions Cohort Corona coronavirus COVID-19 develop disorders Effect ENhance evaluated immune protection immunoassay individual induction infecting Infection Kingdom levels of antibody Pfizer/BioNTech proportion protective immunity SARS-CoV-2 significant increase significantly Sinopharm spike Spike protein Testing the S protein vaccinated individual vaccination Vaccination strategy Vaccine were given [DOI] 10.3389/fimmu.2022.817597 PMC 바로가기 [Article Type] Article
Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients Research Published on 2022-05-192022-10-05 Journal: Communications Medicine [Category] 치료기술, 치료법, [키워드] Adaptive immune response Analysis association blood sample Characteristics chronic illnesses Clinical data collected contribute convalescent COVID-19 patient convalescent patient COVID-19 patient diagnosis of SARS-CoV-2 Health heterogeneity Hong Kong Infection initial laboratory data latent class neutralising antibody occur Older Patient performed Prevent Re-infection Regression model Result risk SARS-CoV-2 SARS-COV-2 infection Seroconversion subject subsequent surveillance data sVNT symptomatic symptomatic patient Symptomatic patients tested the SARS-CoV-2 trajectory Vaccination strategy Variability virus clearance Virus neutralisation were measured [DOI] 10.1038/s43856-022-00119-2 [Article Type] Research
Rapid Hypermutation B Cell Trajectory Recruits Previously Primed B Cells Upon Third SARS-Cov-2 mRNA Vaccination신속한 과돌연변이 B 세포 궤적은 세 번째 SARS-Cov-2 mRNA 백신 접종 시 이전에 준비된 B 세포를 모집합니다Article Published on 2022-05-092022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] antibody antibody affinity Antibody titer Antibody titers Antigen B cell B cell maturation B.1.1.529 booster booster vaccination clone COVID-19 COVID-19 pandemic Delta determine explain high affinity hypermutation immunization Immunoglobulin mRNA mutated mutations naïve Next-generation sequencing offer omicron Omicron variant priority protocol Rapid SARS-CoV-2 strain the SARS-CoV-2 trajectory vaccination Vaccination strategies Vaccination strategy Vaccine variant Viral viral strain Viral variants [DOI] 10.3389/fimmu.2022.876306 PMC 바로가기 [Article Type] Article
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India인도에서 SARS-CoV-2 백신 용량 분류의 비교 비용 효율성 모델링Article Published on 2022-05-012022-09-11 Journal: Nature Medicine [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, [키워드] alternatives benefit build coronavirus disease Coronavirus disease 2019 COVID-19 death distributions dose effective Hospital admission Hospitalization India modeling public health reducing SARS-CoV-2 vaccine Transmissibility Transmission vaccination Vaccination strategy Vaccine vaccine dose vaccine doses variant variants of concern [DOI] 10.1038/s41591-022-01736-z PMC 바로가기 [Article Type] Article
SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19이식 수혜자를 위한 SARS-CoV-2 항체 테스트: COVID-19에 대한 개인화 보호 도구Article Published on 2022-05-012022-09-12 Journal: American journal of transplantation : official jou [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Anti-spike anti-spike antibody Antibody testing COVID-19 drug effort food IMPROVE monoclonal antibody powerful tool Prophylaxis recipient recipients response risk risk stratification SARS-CoV-2 antibody testing SARS-CoV-2 vaccine Seronegativity Society solid organ transplant SOT tested testing antibody transplantation vaccination Vaccination strategy [DOI] 10.1111/ajt.16993 PMC 바로가기 [Article Type] Article
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA VaccinationBNT162b2 COVID-19 mRNA 백신 접종 후 6개월 후의 SARS-CoV-2 변이체에 대한 백신 유도 항체 반응Article Published on 2022-04-272022-09-11 Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration Alpha anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody antibody levels Beta BNT162b2 BNT162b2 vaccine booster dose booster doses collected coronavirus COVID-19 COVID-19 disease COVID-19 mRNA vaccine COVID-19 mRNA vaccines D614G decrease Delta delta variant detectable dose effective Efficacy Eta fold Health care Health care worker immune evasion immune responses Lineage Month mRNA mRNA vaccine mRNA vaccines neutralization neutralize neutralized Neutralizing Neutralizing antibodies new virus of BNT162b2 persistence postvaccination raised receiving reduced reduction respiratory response responses SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 spike protein SARS-CoV-2 variant sera severe acute respiratory syndrome Coronavirus severe COVID-19 disease specific antibodies Transmissibility vaccination Vaccination strategies Vaccination strategy Vaccine vaccine efficacy vaccinees Vaccines variant variants [DOI] 10.1128/spectrum.02252-21 PMC 바로가기 [Article Type] Article